Fresenius Medical Care | FME - Cash And Equivalent

Stock Price
39.28
Daily Change
1.04 2.72%
Monthly
5.79%
Yearly
-13.78%
Q1 Forecast
40.13

Fresenius Medical Care reported EUR1.26B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Akzo Nobel EUR 1.55B 47M Jun/2025
Alcon AG USD 1.5B 90M Sep/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
Bayer EUR 5.9B 1.34B Sep/2025
Beiersdorf EUR 1.17B 40M Jun/2025
DaVita Healthcare Partners USD 676.44M 29.52M Dec/2025
Demant DKK 1.33B 188M Dec/2025
E.ON EUR 3.1B 768M Sep/2025
Essilor EUR 2.79B 535M Jun/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.26B 459.13M Sep/2025
Genmab DKK 1.3B 323M Jun/2025
Getinge SEK 2.96B 720M Dec/2024
Givaudan CHF 603M 3M Jun/2024
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GN Store Nord DKK 767M 363M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Lonza CHF 1.11B 286M Dec/2024
Merck EUR 1.17B 161M Jun/2025
Novartis USD 9.56B 2.9B Sep/2025
Philips EUR 1.91B 90M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
RWE EUR 3.05B 292M Sep/2025
Sanofi EUR 7.66B 1.25B Dec/2025
SAP EUR 8.22B 334M Dec/2025